FBRX SCHEDULE 13G/A: SEC filing
Affinity Asset Advisors, LLC and Michael Cho
Filed with the SEC on · accession 0001011438-26-000693
FBRX filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 13, 2026. A report the company filed with the SEC (the US market regulator).
Summary of the filing
Affinity Asset Advisors, LLC and Michael Cho filed an amended Schedule 13G reporting beneficial ownership of 0 shares (0.0%) of Forte Biosciences common stock as of September 30, 2026, indicating they no longer hold any position in the company.
Key details
✦ Ask GOAX AI about this filing — what it means for FBRX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for FBRX?
Click hereFrequently asked questions
What did FBRX file with the SEC on Nov 13, 2026?
FBRX filed a SCHEDULE 13G/A (SEC filing). Affinity Asset Advisors, LLC and Michael Cho filed an amended Schedule 13G reporting beneficial ownership of 0 shares (0.0%) of Forte Biosciences common stock as of September 30, 2026, indicating they no longer hold any position in the company.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
Other FBRX SEC filings
- SCHEDULE 13G/A · SEC filingNov 13, 2026
- SCHEDULE 13G/A · SEC filingNov 4, 2026
- SCHEDULE 13G/A · SEC filingSep 8, 2026
- EFFECT · SEC filingSep 1, 2026
- EFFECT · SEC filingSep 1, 2026
- EFFECT · SEC filingSep 1, 2026
- EFFECT · SEC filingSep 1, 2026
- EFFECT · SEC filingSep 1, 2026
- EFFECT · SEC filingSep 1, 2026
- 8-K · AcquisitionAug 27, 2026
Get alerts when FBRX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days